Home/Optellum/Jason Pesterfield

JP

Jason Pesterfield

CEO, Optellum Inc. (US)

Therapeutic Areas

Oncology Lung Cancer

Optellum Pipeline

Drug	Indication	Phase
Virtual Nodule Clinic	Lung Nodule Characterization / Early Lung Cancer Diagnosis	Approved

Leadership Team at Optellum

Václav Potěšil, PhD

Co-founder & CEO

Professor Sir Michael Brady

Co-founder & Chairman

Professor Timor Kadir

Co-founder & Chief Science & Technology Officer

View full Optellum profile